A detailed history of Mosley Wealth Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Mosley Wealth Management holds 4,020 shares of NVO stock, worth $341,700. This represents 0.32% of its overall portfolio holdings.

Number of Shares
4,020
Previous 3,420 17.54%
Holding current value
$341,700
Previous $488 Million 3.38%
% of portfolio
0.32%
Previous 0.42%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $71,442 - $87,251
600 Added 17.54%
4,020 $472 Million
Q2 2024

Aug 06, 2024

SELL
$122.71 - $146.91 $83,442 - $99,898
-680 Reduced 16.59%
3,420 $488 Million
Q1 2024

Apr 15, 2024

SELL
$102.11 - $135.92 $29,509 - $39,280
-289 Reduced 6.58%
4,100 $526 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $385,266 - $462,820
4,389 New
4,389 $454 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mosley Wealth Management Portfolio

Follow Mosley Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mosley Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Mosley Wealth Management with notifications on news.